- Home
- FULC vs ROOT Comparison
FULC vs ROOT Comparison
Compare FULC & ROOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$7.93
Company Overview
Basic Information| Metric | FULC | ROOT |
|---|---|---|
| Founded | 2015 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 718.4M | 804.6M |
| IPO Year | 2019 | 2020 |
Fundamental Metrics
Financial Performance| Metric | FULC | ROOT |
|---|---|---|
| Price | $7.93 | $45.29 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 5 |
| Target Price | $16.38 | ★ $108.40 |
| AVG Volume (30 Days) | ★ 1.0M | 362.3K |
| Earning Date | 05-19-2026 | 05-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 28.96 |
| EPS | N/A | ★ 2.36 |
| Revenue | N/A | ★ $1,517,100,000.00 |
| Revenue This Year | N/A | $10.08 |
| Revenue Next Year | N/A | $12.63 |
| P/E Ratio | ★ N/A | $20.43 |
| Revenue Growth | N/A | ★ 28.95 |
| 52 Week Low | $2.32 | $46.42 |
| 52 Week High | $15.74 | $181.14 |
Technical Indicators
Market Signals| Indicator | FULC | ROOT |
|---|---|---|
| Relative Strength Index (RSI) | 34.80 | 29.85 |
| Support Level | $6.33 | N/A |
| Resistance Level | $8.50 | $88.63 |
| Average True Range (ATR) | 0.80 | 3.31 |
| MACD | -0.17 | -0.79 |
| Stochastic Oscillator | 9.31 | 6.01 |
Price Performance
Historical Comparison FULC
ROOT
About FULC Fulcrum Therapeutics Inc.
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.
About ROOT Root Inc.
Root Inc develops and launches a direct-to-consumer personal automobile insurance and mobile technology company. It generates revenue from the sales of auto insurance policies within the United States.